Target
Cyclin-dependent kinase 9
Ligand
BDBM307745
Substrate
n/a
Meas. Tech.
TR-FRET Kinase Assay
IC50
28.0±n/a nM
Citation
 Mastracchio, ABruncko, MLai, CMiyashiro, JMTao, ZWoods, KWPenning, TDSouers, AJ Pyridine CDK9 kinase inhibitors US Patent  US9650358 Publication Date 5/16/2017 
Target
Name:
Cyclin-dependent kinase 9
Synonyms:
C-2K | CDC2L4 | CDK9 | CDK9_HUMAN | Cell division cycle 2-like protein kinase 4 | Cell division protein kinase 9 | Cyclin-Dependent Kinase 9 (CDK9) | Cyclin-dependent kinase 9 (CDK9) | Serine/threonine-protein kinase PITALRE | TAK | Tat-associated kinase complex catalytic subunit
Type:
Enzyme Subunit
Mol. Mass.:
42789.13
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
372
Sequence:
MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKGSQITQQSTNQSRNPATTNQTEFERVF
  
Inhibitor
Name:
BDBM307745
Synonyms:
5-chloro-N-[2-(1-ethylpiperidin-4-yl)ethyl]-4-[1-(3-fluorobenzyl)-1H-benzimidazol-6-yl]pyridin-2-amine | US9650358, Example 41
Type:
Small organic molecule
Emp. Form.:
C28H31ClFN5
Mol. Mass.:
492.031
SMILES:
CCN1CCC(CCNc2cc(c(Cl)cn2)-c2ccc3ncn(Cc4cccc(F)c4)c3c2)CC1
Structure:
Search PDB for entries with ligand similarity: